Rwandan health authorities have taken swift action following safety concerns surrounding antifungal tablets produced in Kenya.
The Rwanda Food and Drugs Authority (RFDA) issued a recall notice for all batches of 200 mg Fluconazole tablets manufactured by the Kenyan company Universal Corporation.
The directive, aimed at importers, mandates the return of these tablets due to discolouration issues discovered by the RFDA.
Specifically, four bulk batches of pink Fluconazole 200mg tablets showed white discolouration shortly after their shelf life began once imported into Rwanda.
Highlighting the urgency of the situation, the RFDA emphasized that some of these discoloured tablets had already entered the Rwandan market.
Consequently, retailers and health facilities have been instructed to cease distribution and return the affected drugs immediately.
As a precautionary measure, health officials in Rwanda have launched an investigation to ascertain whether these potentially compromised drugs have caused any adverse effects among consumers.
Amid these developments, Kenyan authorities are yet to announce whether the same antifungal drug, commonly used to treat fungal or yeast infections, will also undergo a recall within the local market.
Read: Ned Nwoke: Nigerians Should Be Allowed to Carry Guns
About The Author
Related Articles
Tinubu’s Government Demands New Tax ID for Every Nigerian While Bandits Keep Kidnapping, Hunger Bites, and Electricity Dies
Just as families across Nigeria are burying loved ones killed by bandits...
More Than 1,100 Abducted in Four Months While Tinubu’s Campaign Machinery Moves Quietly Toward a Second Term
As heavily armed bandits behead a teacher in Oyo State, kill a...
AES Pushes Resource Control as Niger Secures $1 Billion Oil Pact With China
Niger’s military led government has signed a sweeping series of oil agreements...
Ghana Seeks Bigger Share of Gold Wealth With New Refining Mandate
Ghana has launched an ambitious plan to secure a larger share of...